Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Public ClinicalTrials.gov record NCT00110487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.
Study identification
- NCT ID
- NCT00110487
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Not listed
- Completion
- Nov 30, 2006
- Last update posted
- Apr 30, 2015
2005 – 2006
United States locations
- U.S. sites
- 46
- U.S. states
- 23
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85015 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Carmichael | California | 95608 | — |
| Not listed | La Jolla | California | 92093 | — |
| Not listed | Redding | California | 96001 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Lakewood | Colorado | 80228 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Boynton Beach | Florida | 33437 | — |
| Not listed | Celebration | Florida | 34747 | — |
| Not listed | Clearwater | Florida | 33758 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | New Port Richey | Florida | 34652 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Palm Harbor | Florida | 34684 | — |
| Not listed | Alpharetta | Georgia | 30005 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Arlington Heights | Illinois | 60005 | — |
| Not listed | Champaign | Illinois | 61820 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Oak Brook | Illinois | 60523 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Lanham | Maryland | 20706 | — |
| Not listed | Laurel | Maryland | 20707 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Chaska | Minnesota | 55318 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Las Vegas | Nevada | 89104 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Fargo | North Dakota | 58104 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Eugene | Oregon | 97401 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Greer | South Carolina | 29651 | — |
| Not listed | Dallas | Texas | 75390-9032 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Webster | Texas | 77598 | — |
| Not listed | Sandy City | Utah | 84070 | — |
| Not listed | Norfolk | Virginia | 23507-1627 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Madison | Wisconsin | 53792-6188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00110487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00110487 live on ClinicalTrials.gov.